I don't know anything about VAL Bojo and I'm not saying it's a bad company. I was just talking in general terms. A lot of people have probably got burnt so will be more cautious on other investments. That's not necessarily a bad thing as too much speculation is not good for any of us as it can spread and cause problems for other investors.
I still remain positive here let's hope we get good news.
There may not be enough shares available to buy in the market. I would wait for progress at Truspine first. They have the FDA submission to make yet and that may or may not get approved and there could be delays in the submission and/or approval from fda. On approval obviously the price will go up but the prospects would have also improved. There will be further funding rounds yet when we will have chance to subscribe if it is in out interests to do so.
Otherwise our pf will become too heavy in very early stage companies which Truspine still is - even after FDA approval sales will take some time to build up and then presumably they will have to apply for further FDA approvals on their other products.
I'm not too keen on us investing too heavily in these early stage companies unless we are getting the shares at a big discount. We didn't get any discount it seems on Truspine. We have done better in the prices obtained on the other companies such as Engage and Fresho.
I always aim to be in quality businesses in case there is a downturn and then you're stuck with them. The quality businesses are more likely to pull through/survive over the long term.
During the dot com craze of the late 90's all sorts of rubbish increased as well as the good businesses and then investors were left holding them many of which went bust later.
I'm not sure if biotech valuations are over stretched here - I would say not but over the pond they probably are? They have always been high there though you have biotech companies valued in the billions there that would be worth maybe 200-300 million here. Strange that.
With Imm the management leaves a lot to be desired but I'm holding it on "value" principles and hoping the science pulls us through in spite of the management.
Yes this company hasn't failed us. I expect a whole load of new products and sales in the next few months including a lateral flow test - I'm really confident that the company will be working on one. Why wouldn't they? They are a leading diagnostic company and have a.division already that makes these for other tests.
RE: True Current Value £1bn SP£1530 Sep 2020 12:21
Some consolidation is a good thing to build a strong base before the next move up.
We were only £3 at the beginning of September so this is a good level before the next moves up. The move up to this level has been smooth as well so that is good.
We are undervalued but like someone said this morning nothing goes up in a straight line so patience is required imo.
We are making strong sales and the old year end revenue forecasts have already been smashed with the latest government deal. It's just that Nova aren't going to come out and say look at all this money we are making from this virus. They have too big a customer in the government s of the UK and France to do that.
Hey not even a £5 million Hungary order gets a mention. That's saying something.
It is disappointing but which one of these companies has actually met the deadlines at the moment?
You have even Aau (I'm invested and that is coming good now) where investors have been waiting since last year for the new investor to come on board. You have delays in other companies as well for permits/funding such as bmv, grl, Conroy gold, keras resources etc.
I'm quite new to the mining sector but these kind of delays are common. It's whether people think the deal will go through eventually or not.
80 million market cap when Alkindi worldwide sales alone will give it a p/e ratio of 20 (low for a growth biotech) for a market cap well in excess of several hundred million pounds. That's before anything else kicks in from the other drugs. Can see this being a long term core holding in my pf.
RE: If Carlsberg did AIM shares is would be NCYT30 Sep 2020 00:04
Here's a post from the man himself protecting people from the rampers at 39p. Can see why you call him 9inchfail. People like him will always be spectators while others make the money:
Posted in: NCYT
RE: There is room for more than one supplier31 Jan 2020 22:41 This share is now the UK's favourite ramp, thanks to coronavirus. Beware, it can go down as quickly as it rises. A testing kit, but today 2 Chinese tourists were tested in the UK as being infected. Is there a shortage of test kits, maybe if hundreds or thousands become ill. Who knows eh? Time to stay indoors and keep them hands washed."
I always look at what the company is doing first and then the share price. The share price will eventually catch up with business performance. I think we can all sleep sounder now in the knowledge there is more to come as well.